Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.
Financial Results:
Themis Medicare Ltd reported Revenues for Q2FY24 of ₹105.00 Crores up from ₹91.00 Crore year on year, a rise of 15.38%.
Total Expenses for Q2FY24 of ₹97.00 Crores up from ₹75.00 Crores year on year, a rise of 29.33%.
Consolidated Net Profit of ₹11.00 Crores down 38.89% from ₹18.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.23, down 36.27% from ₹1.93 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.